For Healthcare Professionals

REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy


About the study

This study is investigating whether breast cancer patients who experience vaginal dryness while on anti-estrogen treatment could benefit from either vaginal estrogen or from a vaginal moisturizer called Replens.

Who can take part

You may be eligible to participate in the study if you meet the following criteria:


Inclusion Criteria:

  1. be female
  2. be 18 years of age or older.
  3. have stage I-III ER+ breast cancer
  4. be post-menopausal as defined by any of the following: age >55 years, history of bilateral oophorectomy, amenorrhea for 1 year with intact uterus and ovaries, or serum estradiol and FSH concentrations in the post-menopausal range along with either amenorrhea for 6 months or previous hysterectomy.
  5. currently take adjuvant AI therapy
  6. have vaginal dryness, dyspareunia, or ≥3 urinary tract infections per year since starting AI therapy
  7. Patients must agree not to use any additional estrogen during the five year study period. However, use of non-estrogen containing lubricants prior to sexual intercourse, or otherwise, is allowed.


Exclusion Criteria:

  1. use of any exogenous estrogen within the preceding four weeks
  2. current vaginal infection.

pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply

Contact the study center to learn if this study is a good match for you.

Study’s details


Estrogen Receptor Positive Breast Cancer,Breast Cancer

Age (in years)



Phase 2

Participants needed


Est. Completion Date

Jul 31, 2024

Treatment type



The Methodist Hospital Research Institute identifier


Study number


Understanding Clinical Trials

Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?


Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.